Relay Therapeutics, Inc. (RLAY): A Bull Case Theory

We came across a bullish thesis on Relay Therapeutics, Inc. (RLAY) on Substack by Steve Wagner | Invest. In this article, we will summarize the bulls’ thesis on RLAY. Relay Therapeutics, Inc. (RLAY)'s share was trading at $4.78 as of Dec 12^th.

[caption id="attachment_1206761" align="aligncenter" width="768"] A scientist holding a test tube in the lab, surrounded by equipment used in synthetic biology and drug discovery.[/caption]

Relay Therapeutics (RLAY) has unveiled promising interim data for RLY-2608, its groundbreaking allosteric PI3Kα inhibitor, in combination with...